V
Vinícius Paganini Nascimento
Researcher at University of São Paulo
Publications - 7
Citations - 61
Vinícius Paganini Nascimento is an academic researcher from University of São Paulo. The author has contributed to research in topics: Visual acuity & Diabetic retinopathy. The author has an hindex of 4, co-authored 7 publications receiving 57 citations.
Papers
More filters
Journal ArticleDOI
Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.
Otacílio de Oliveira Maia Júnior,Maria Teresa Brizzi Chizzotti Bonanomi,Walter Yukihiko Takahashi,Vinícius Paganini Nascimento,Beatriz Sayuri Takahashi +4 more
TL;DR: A single intravitreal bevacizumab injection provides short-term improvement in visual acuity and foveal detachment associated with IPT and should be followed by further studies to evaluate the long-term effects on retinal structure and function.
Journal ArticleDOI
Injeção intravítrea de triancinolona no tratamento da telangiectasia retiniana justafoveolar idiopática
Otacílio de Oliveira Maia Júnior,Walter Yukihiko Takahashi,Maria Teresa Brizzi Chizzotti Bonanomi,Vinícius Paganini Nascimento,Carlos Sérgio Nascimento de Melo +4 more
TL;DR: The stabilization of the vascular wall due to the intravitreal triamcinolone injection leads to a transitory improvement in vision and reduction in macular edema in the TJI 1A eyes.
Journal ArticleDOI
Relationship between diabetic retinopathy severity and the timespan between the endocrinopathy diagnosis and the first ophthalmic examination
Rony Carlos Preti,Augusto Motta,Otacílio de Oliveira Maia Júnior,Celso Morita,Vinícius Paganini Nascimento,Mário Luiz Ribeiro Monteiro,Walter Yukihiko Takahashi +6 more
TL;DR: This study showed a statistically significant relationship between the time interval from the diagnosis of type 2 DM and the first fundoscopic examination with the severity of DR.
Journal ArticleDOI
Injeção intravítrea de bevacizumabe ou triancinolona como adjuvantes da vitrectomia posterior no tratamento da hemorragia vítrea em diabéticos
Daniel Ferraz,Celso Morita,Rony Carlos Preti,Vinícius Paganini Nascimento,Otacílio de Oliveira Maia Júnior,André Carvalho de Barros,Beatriz Sayuri Takahashi,Walter Yukihiko Takahashi +7 more
TL;DR: Intravitreal injection of bevacizumab 1 week before vitrectomy seems to reduce the incidence of early postvitrectomy hemorrhage in diabetic patients and there was a better visual acuity outcome in the triamcinolone group.
Journal ArticleDOI
Analgesic effect of etoricoxib (Arcoxia®) 120 mg during retinal laser photocoagulation.
Vinícius Paganini Nascimento,Hélio Paulo Primiano,Otacílio de Oliveira Maia,David E. Pelayes,Walter Yukihiko Takahashi +4 more
TL;DR: Etoricoxib 120 mg reduces pain and can be used before panphotocoagulation and data show that the medication is more effective against pain during photocoagulated than placebo.